tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
US Market

KalVista Pharmaceuticals (KALV) Technical Analysis

Compare
573 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
KalVista Pharmaceuticals’s (KALV) Moving Averages Convergence Divergence (MACD) indicator is 1.21, suggesting KalVista Pharmaceuticals is a Sell.
KalVista Pharmaceuticals’s (KALV) 20-Day exponential moving average is 14.98, while KalVista Pharmaceuticals’s (KALV) share price is $16.91, making it a Buy.
KalVista Pharmaceuticals’s (KALV) 50-Day exponential moving average is 13.69, while KalVista Pharmaceuticals’s (KALV) share price is $16.91, making it a Buy.

KalVista Pharmaceuticals (KALV) Pivot Points

Dec 15, 2025, 03:18 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.85
16.13
16.52
16.80
17.19
17.47
17.86
Fibonacci
16.13
16.39
16.55
16.80
17.06
17.22
17.47
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

KalVista Pharmaceuticals (KALV) Moving Averages

Dec 15, 2025, 03:18 AM
Period
Simple
Exponential
MA5
16.74Buy
16.62Buy
MA10
15.86Buy
16.00Buy
MA20
14.82Buy
14.98Buy
MA50
12.73Buy
13.69Buy
MA100
13.09Buy
13.15Buy
MA200
12.83Buy
12.34Buy
KalVista Pharmaceuticals’s (KALV) 10-Day exponential moving average is 16.00, while KalVista Pharmaceuticals’s (KALV) share price is $16.91, making it a Buy.
KalVista Pharmaceuticals’s (KALV) 100-Day exponential moving average is 13.15, while KalVista Pharmaceuticals’s (KALV) share price is $16.91, making it a Buy.
KalVista Pharmaceuticals’s (KALV) stock price is $16.91 and KalVista Pharmaceuticals’s (KALV) 50-day simple moving average is 12.73, creating a Buy signal.
KalVista Pharmaceuticals’s (KALV) stock price is $16.91 and KalVista Pharmaceuticals’s (KALV) 100-day simple moving average is 13.09, creating a Buy signal.
KalVista Pharmaceuticals’s (KALV) stock price is $16.91 and KalVista Pharmaceuticals’s (KALV) 200-day simple moving average is 12.83, creating a Buy signal.

KalVista Pharmaceuticals (KALV) Technical Indicators

Dec 15, 2025, 03:18 AM
Name
Value
Implied Action
RSI (14)
69.68
Neutral
STOCH (9,6)
94.09
Sell
STOCHRSI (14)
94.62
Sell
MACD (12,26)
1.21
Sell
ADX (14)
36.82
Neutral
Williams %R
-5.87
Sell
CCI (14)
112.10
Sell
ATR (14)
0.99
-
Ultimate Oscillator
65.10
Neutral
ROC
29.08
Buy
KalVista Pharmaceuticals’s (KALV) Relative Strength Index (RSI) is 69.68, creating a Neutral signal.
KalVista Pharmaceuticals’s (KALV) Trend Strength Indicator (ADX) is 36.82, creating a Neutral signal.
KalVista Pharmaceuticals’s (KALV) Commodity Channel Index (CCI) is 112.10, creating a Sell signal.
KalVista Pharmaceuticals’s (KALV) Price Rate of Change (ROC) is 29.08, creating a Buy signal.

FAQ

Is KALV a Buy, Hold, or Sell?
Based on KALV’s technical indicators, KALV is a Buy.
    What is KALV’s RSI (14)?
    KALV’s RSI (14) is 69.68, which suggests KALV is a Neutral.
      What is KALV’s MACD?
      KALV’s MACD is 1.21, which suggests KALV is a Sell.
        What is KALV’s 5-day moving average?
        KALV’s 5-day moving average is 16.74, which suggests KALV is a Buy.
          What is KALV’s 20-day moving average?
          KALV 20-day moving average is 14.82, which suggests KALV is a Buy.
            What is KALV’s 50-day moving average?
            KALV’s 50-day moving average is 12.73, which suggests KALV is a Buy.
              What is KALV’s 200-day moving average?
              KALV’s 200-day moving average is 12.83, which suggests KALV is a Buy.
                What is KALV’s Williams % R (14)?
                KALV’s Williams % R (14) is -5.87, which suggests KALV is a Sell.
                  What is KALV’s CCI (14)?
                  KALV’s CCI (14) is 112.10, which suggests KALV is a Sell.